Chemistry:TC-2216

From HandWiki
Short description: Chemical compound
TC-2216
TC-2216.svg
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC12H17N3
Molar mass203.283 g·mol−1
3D model (JSmol)
  (verify)

TC-2216 is a drug developed by Targacept which acts as a partial agonist at neural nicotinic acetylcholine receptors and was researched for the treatment of anxiety and depression.[1] It was unsuccessful as a therapeutic but is still used in pharmacological research as an alpha4beta2-selective antagonist.[2]

References

  1. "Central nicotinic receptors: structure, function, ligands, and therapeutic potential". ChemMedChem 2 (6): 746–67. June 2007. doi:10.1002/cmdc.200600207. PMID 17295372. 
  2. "TC-5214 (S-(+)-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activity". CNS Neuroscience & Therapeutics 14 (4): 266–77. 2008. doi:10.1111/j.1755-5949.2008.00054.x. PMID 19040552.